Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

SVP and CFO

SVP, CCO

SVP, General Counsel

See Remarks

President & CEO

SVP and CAO

President and CEO

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 1995 and is headquartered in Lake Forest, Illinois.

Assertio Holdings, Inc., a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inf...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-14	Premium	sold	Premium	Premium	Premium	-
2024-02-21	Premium	acquired	Premium	Premium	Premium	SVP and CFO
2024-02-21	Premium	sold (taxes)	Premium	Premium	Premium	SVP, CCO
2024-02-21	Premium	sold (taxes)	Premium	Premium	Premium	SVP, General Counsel
2024-02-21	Premium	acquired	Premium	Premium	Premium	SVP, General Counsel
2024-02-21	Premium	acquired	Premium	Premium	Premium	SVP, CCO
2024-02-21	Premium	sold (taxes)	Premium	Premium	Premium	SVP and CFO
2024-02-11	Premium	acquired	Premium	Premium	Premium	See Remarks
2024-02-11	Premium	acquired	Premium	Premium	Premium	SVP, General Counsel
2024-02-11	Premium	acquired	Premium	Premium	Premium	SVP and CFO
2024-02-11	Premium	sold (taxes)	Premium	Premium	Premium	See Remarks
2024-02-11	Premium	sold (taxes)	Premium	Premium	Premium	SVP, General Counsel
2024-02-11	Premium	sold (taxes)	Premium	Premium	Premium	SVP and CFO
2023-11-14	Premium	acquired	Premium	Premium	Premium	-
2023-10-01	Premium	sold (taxes)	Premium	Premium	Premium	SVP, General Counsel
2023-10-01	Premium	acquired	Premium	Premium	Premium	SVP, General Counsel
2023-09-12	Premium	sold	Premium	Premium	Premium	President & CEO
2023-09-11	Premium	sold	Premium	Premium	Premium	SVP and CFO
2023-09-11	Premium	sold	Premium	Premium	Premium	SVP and CAO
2023-09-11	Premium	sold	Premium	Premium	Premium	President & CEO
2023-09-11	Premium	sold	Premium	Premium	Premium	SVP, General Counsel
2023-08-14	Premium	sold	Premium	Premium	Premium	-
2023-08-05	Premium	acquired	Premium	Premium	Premium	SVP, General Counsel
2023-08-05	Premium	sold (taxes)	Premium	Premium	Premium	SVP, General Counsel
2023-07-31	Premium	acquired	Premium	Premium	Premium	-

ASRT - Assertio Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ASRT